Fate Therapeutics (FATE) Other Non-Current Liabilities (2012 - 2026)
Fate Therapeutics (FATE) recorded Other Liabilities of $943,000 in Q2 2026, up 194.7% from $320,000 a year earlier and up 159.8% from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
At the end of FY2025, Fate Therapeutics reported Other Liabilities of $283,000, down 46.3% from FY2024.
- Annual Other Liabilities has declined for four straight years, with a five-year compound annual growth rate of -52.5% (FY2020 to FY2025).
- Across earlier years, Other Liabilities came in at $527,000 in FY2024 (-60.8%), $1.35 million in FY2023 (-65.1%), $3.86 million in FY2022 (-84.0%) and $24.17 million in FY2021 (+106.8%).
- The Q2 2026 figure is the highest quarterly Other Liabilities since Q3 2024.
- On a year-over-year basis, Other Liabilities rose in three of the last eight quarters, with an average decline of 3.1%.
- Peak year-over-year performance for Other Liabilities in the last five years was growth of 194.7% in Q2 2026, against a decline of 92.2% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $363,000 (Q1 2026), $283,000 (Q4 2025) and $410,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Fate Therapeutics | 215.18 Mn | 76.08 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 792,000.00 |
| Jun 30, 2026 | 943,000.00 |
| Mar 31, 2026 | 363,000.00 |
| Dec 31, 2025 | 283,000.00 |
| Sep 30, 2025 | 410,000.00 |
| Jun 30, 2025 | 320,000.00 |
| Mar 31, 2025 | 247,000.00 |
| Dec 31, 2024 | 527,000.00 |
| Sep 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 1.35 Mn |
| Sep 30, 2023 | 701,000.00 |
| Jun 30, 2023 | 1.75 Mn |
| Mar 31, 2023 | 2.14 Mn |
| Dec 31, 2022 | 3.86 Mn |
| Sep 30, 2022 | 9.04 Mn |
| Jun 30, 2022 | 9.93 Mn |
| Mar 31, 2022 | 15.81 Mn |
| Dec 31, 2021 | 24.17 Mn |
API Access
Fate Therapeutics Other Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-liabilities", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();